Overview
- Palantir reported Q1 revenue of $1.63 billion, up 85% from a year ago, with adjusted earnings of $0.33 per share and a raised full-year sales outlook to at least $7.65 billion.
- U.S. demand accelerated as government spending with Palantir reached $687 million year over year, with the Pentagon doubling use of the company’s Maven targeting system over four months.
- The company highlighted a $484 million U.S. Navy ShipOS contract that it says is cutting approval and planning steps, including one parts check that fell from 200 hours to 15 seconds.
- Analysts said the results point to AI moving from small tests to daily operations, and executives cited rising U.S. customer commitments to back that view.
- In the UK, a £330 million NHS data platform deal drew renewed scrutiny, and Palantir’s UK chief said the firm cannot access patient medical records.